Stonegate Investment Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Buy |
37,428
+4,917
| +15% | +$339K | 0.06% | 118 |
|
|
2025
Q1 | $2.26M | Buy |
32,511
+912
| +3% | +$63.3K | 0.06% | 117 |
|
|
2024
Q4 | $2.72M | Buy |
31,599
+1,308
| +4% | +$113K | 0.07% | 104 |
|
|
2024
Q3 | $3.61M | Buy |
30,291
+677
| +2% | +$80.6K | 0.1% | 86 |
|
|
2024
Q2 | $4.23M | Buy |
29,614
+698
| +2% | +$99.6K | 0.12% | 78 |
|
|
2024
Q1 | $3.71M | Buy |
28,916
+3,536
| +14% | +$454K | 0.12% | 84 |
|
|
2023
Q4 | $2.63M | Buy |
25,380
+5,248
| +26% | +$543K | 0.09% | 93 |
|
|
2023
Q3 | $1.83M | Sell |
20,132
-344
| -2% | -$31.3K | 0.07% | 113 |
|
|
2023
Q2 | $1.66M | Sell |
20,476
-298
| -1% | -$24.1K | 0.06% | 127 |
|
|
2023
Q1 | $1.65M | Buy |
20,774
+4,074
| +24% | +$324K | 0.06% | 119 |
|
|
2022
Q4 | $1.13M | Buy |
+16,700
| New | +$1.13M | 0.05% | 134 |
|